Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$98.85 - $138.91 $1.48 Million - $2.08 Million
-15,000 Closed
0 $0
Q2 2021

Sep 21, 2023

SELL
$65.78 - $105.02 $1.57 Million - $2.5 Million
-23,800 Reduced 61.34%
15,000 $1.46 Million
Q2 2021

Aug 20, 2021

SELL
$65.78 - $105.02 $97.7 Million - $156 Million
-1,485,000 Reduced 99.0%
15,000 $1.46 Million
Q2 2021

Aug 16, 2021

BUY
$65.78 - $105.02 $98.7 Million - $158 Million
1,500,000 New
1,500,000 $1.46 Million
Q1 2021

May 14, 2021

SELL
$64.07 - $91.75 $2.49 Million - $3.56 Million
-38,800 Closed
0 $0
Q4 2020

Sep 21, 2023

BUY
$65.07 - $98.24 $2.52 Million - $3.81 Million
38,800 New
38,800 $3.33 Million
Q4 2020

Feb 16, 2021

SELL
$65.07 - $98.24 $162,674 - $245,600
-2,500 Reduced 6.05%
38,800 $3.33 Million
Q1 2020

May 15, 2020

SELL
$27.51 - $57.29 $13.6 Million - $28.4 Million
-495,400 Reduced 92.3%
41,300 $0
Q4 2019

Feb 13, 2020

BUY
$40.86 - $57.65 $19.3 Million - $27.2 Million
472,100 Added 730.8%
536,700 $0
Q3 2019

Nov 13, 2019

SELL
$37.38 - $49.47 $684,054 - $905,301
-18,300 Reduced 22.07%
64,600 $0
Q2 2019

Aug 14, 2019

BUY
$39.79 - $67.01 $2.24 Million - $3.77 Million
56,200 Added 210.49%
82,900 $0
Q1 2019

May 15, 2019

BUY
$34.52 - $53.29 $921,684 - $1.42 Million
26,700 New
26,700 $0

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.